BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 32694690)

  • 1. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.
    Huang B; Song BL; Xu C
    Nat Metab; 2020 Feb; 2(2):132-141. PubMed ID: 32694690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming of the tumour microenvironment.
    Xing Y; Zhao S; Zhou BP; Mi J
    FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol metabolism: New functions and therapeutic approaches in cancer.
    Xu H; Zhou S; Tang Q; Xia H; Bi F
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188394. PubMed ID: 32698040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.
    Goossens P; Rodriguez-Vita J; Etzerodt A; Masse M; Rastoin O; Gouirand V; Ulas T; Papantonopoulou O; Van Eck M; Auphan-Anezin N; Bebien M; Verthuy C; Vu Manh TP; Turner M; Dalod M; Schultze JL; Lawrence T
    Cell Metab; 2019 Jun; 29(6):1376-1389.e4. PubMed ID: 30930171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol metabolism: At the cross road between cancer cells and immune environment.
    Kopecka J; Godel M; Riganti C
    Int J Biochem Cell Biol; 2020 Dec; 129():105876. PubMed ID: 33166677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications.
    Lu J; Chen S; Bai X; Liao M; Qiu Y; Zheng LL; Yu H
    Biochem Pharmacol; 2023 Dec; 218():115907. PubMed ID: 37931664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of induction of tumors by cholesterol and potential therapeutic prospects.
    Xi Y; Yani Z; Jing M; Yinhang W; Xiaohui H; Jing Z; Quan Q; Shuwen H
    Biomed Pharmacother; 2021 Dec; 144():112277. PubMed ID: 34624674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
    Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
    J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Even Cancer Cells Watch Their Cholesterol!
    Riscal R; Skuli N; Simon MC
    Mol Cell; 2019 Oct; 76(2):220-231. PubMed ID: 31586545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.
    Qiu GZ; Jin MZ; Dai JX; Sun W; Feng JH; Jin WL
    Trends Pharmacol Sci; 2017 Aug; 38(8):669-686. PubMed ID: 28602395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Codependencies in the Tumor Microenvironment.
    Dey P; Kimmelman AC; DePinho RA
    Cancer Discov; 2021 May; 11(5):1067-1081. PubMed ID: 33504580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural forms of vitamin E and metabolites-regulation of cancer cell death and underlying mechanisms.
    Jiang Q
    IUBMB Life; 2019 Apr; 71(4):495-506. PubMed ID: 30548200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis.
    Deng CM; Zhang GG; Liu QW; Xu JJ; Liu ZC; Yang J; Xu TY; Li ZG; Zhang F; Li B
    Cancer Res; 2023 Jun; 83(11):1851-1865. PubMed ID: 36912612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between Immune Checkpoint Proteins and Cellular Metabolism.
    Lim S; Phillips JB; Madeira da Silva L; Zhou M; Fodstad O; Owen LB; Tan M
    Cancer Res; 2017 Mar; 77(6):1245-1249. PubMed ID: 28246276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review).
    Yu XH; Ren XH; Liang XH; Tang YL
    Mol Med Rep; 2018 Dec; 18(6):5307-5316. PubMed ID: 30365095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of Reprogramming Breast Cancer Metabolism.
    Wang YP; Lei QY
    Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects.
    Nwabo Kamdje AH; Seke Etet PF; Tagne Simo R; Vecchio L; Lukong KE; Krampera M
    Cancer Biol Med; 2020 Nov; 17(4):828-841. PubMed ID: 33299638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.